Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

2.5K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.5K
T Cell Types and Functions01:24

T Cell Types and Functions

3.1K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.1K
Hypersensitivity Reactions: Delayed Hypersensitivity Reactions01:29

Hypersensitivity Reactions: Delayed Hypersensitivity Reactions

333
Delayed-Type Hypersensitivity (DTH), or Type IV hypersensitivity, is a cell-mediated immune response. It occurs when T cells, rather than antibodies, mediate a reaction to specific antigens. It is characterized by a delayed onset (1-2 days) and involves the recruitment of macrophages to the inflammation site.The initiation of a DTH response begins with the sensitization of T cells. During this phase, which lasts at least 1-2 weeks, antigen-specific T cells are activated, clonally expanded, and...
333

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparative effectiveness of game-based learning modalities in nursing and medical education: a systematic review and Bayesian network meta-analysis.

Nurse education today·2026
Same author

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne·2026
Same author

Regulatory B cell expansion and type 1 innate lymphoid cell suppression characterise immune modulation in paediatric lupus nephritis.

RMD open·2026
Same author

Association between neonatal sepsis and lung function in school-age children born preterm.

Pediatric research·2026
Same author

Insights into Antioxidant Activity and Trace Element Distribution of Aqueous Extract of <i>Silybum marianum</i> Seeds.

Molecules (Basel, Switzerland)·2026
Same author

Multi-Omics Analysis for Identifying Glial Dysfunction-Associated Genes as Therapeutic Targets and Drug Candidates in Alzheimer's Disease.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026

Related Experiment Video

Updated: Apr 21, 2026

Isolation and Th17 Differentiation of Na&#239;ve CD4 T Lymphocytes
12:59

Isolation and Th17 Differentiation of Naïve CD4 T Lymphocytes

Published on: September 26, 2013

33.7K

Low-molecular-weight heparin and unfractionated heparin decrease Th-1, 2, and 17 expressions.

Jing-Ning Huang1, Ming-Chin Tsai1, Shun-Lung Fang2

  • 1Pediatric Department, Taichung Veterans General Hospital, Taichung, Taiwan, Republic of China.

Plos One
|November 4, 2014
PubMed
Summary

Inhaled heparin and low-molecular-weight heparin reduced allergic responses in a mite-allergic mouse model by decreasing T helper cell differentiation. These treatments lowered IgE levels and suppressed key inflammatory markers, suggesting therapeutic potential.

More Related Videos

Author Spotlight: Achieving High-Purity In Vitro Differentiation of Th17 Cells Using Cytokine Concentration Modulation
07:46

Author Spotlight: Achieving High-Purity In Vitro Differentiation of Th17 Cells Using Cytokine Concentration Modulation

Published on: October 25, 2024

3.2K
Small RNA Transfection in Primary Human Th17 Cells by Next Generation Electroporation
10:15

Small RNA Transfection in Primary Human Th17 Cells by Next Generation Electroporation

Published on: April 13, 2017

7.3K

Related Experiment Videos

Last Updated: Apr 21, 2026

Isolation and Th17 Differentiation of Na&#239;ve CD4 T Lymphocytes
12:59

Isolation and Th17 Differentiation of Naïve CD4 T Lymphocytes

Published on: September 26, 2013

33.7K
Author Spotlight: Achieving High-Purity In Vitro Differentiation of Th17 Cells Using Cytokine Concentration Modulation
07:46

Author Spotlight: Achieving High-Purity In Vitro Differentiation of Th17 Cells Using Cytokine Concentration Modulation

Published on: October 25, 2024

3.2K
Small RNA Transfection in Primary Human Th17 Cells by Next Generation Electroporation
10:15

Small RNA Transfection in Primary Human Th17 Cells by Next Generation Electroporation

Published on: April 13, 2017

7.3K

Area of Science:

  • Immunology
  • Allergology
  • Pharmacology

Background:

  • Mite allergy is a significant health concern.
  • T helper cell differentiation plays a crucial role in allergic inflammation.
  • Heparin's therapeutic potential in allergic diseases requires further investigation.

Purpose of the Study:

  • To evaluate the impact of inhaled heparins of varying molecular weights on T helper cell differentiation in a mite-allergic mouse model.
  • To assess the effects of heparin treatment on key immunological markers associated with allergy.

Main Methods:

  • BALB/c mice were sensitized to Der p allergen and divided into control, mite-only, inhaled heparin, and inhaled low-molecular-weight heparin groups.
  • Splenocytes were cultured and stimulated with Der p allergen to analyze cytokine profiles (IL-17A/F, IFN-γ, IL-4, IL-13, IL-10).
  • Serum IgE levels and spleen mRNA expression of key transcription factors (Foxp3, GATA3, RORγt) and cytokines (IL-10, IFN-γ, IL-5) were measured.

Main Results:

  • Both inhaled heparin and low-molecular-weight heparin groups exhibited significantly lower serum IgE levels compared to the mite-only group.
  • Decreased mRNA expression of GATA-3, IFN-γ, IL-5, and RORγt was observed in the spleen of heparin-treated mice.
  • Heparin treatments led to significant reductions in the secretion of IL-17A/F, IFN-γ, IL-4, IL-13, and IL-10 from splenocytes.

Conclusions:

  • Intranasal administration of both heparin and low-molecular-weight heparin effectively reduced T helper cell (Th1, Th2, Th17) expression in the spleen of a mite-allergic mouse model.
  • These findings suggest that inhaled heparins may hold therapeutic promise for managing mite allergy.
  • Further research is warranted to elucidate the precise underlying mechanisms of action.